Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-24T18:22:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:27.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Access to the study record for NCT03332498 now displays a 403 Forbidden error page, replacing the previous content that described the study. This indicates the page is currently blocked or unavailable, preventing viewing the study details on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-19T20:52:28.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6 from v3.6.5, indicating a backend/template update; no study content or participant information appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-29T20:48:22.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance/metadata update rather than a change to core study content.
    Difference
    0.1%
    Check dated 2026-08-08T18:59:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.